Sphingosine kinase inhibitors decrease viability and induce cell death in natural killer-large granular lymphocyte leukemia

Sphingolipid metabolism has been identified as a potential therapeutic target in cancer. Sphingosine-1-phosphate (S1P) is a potent bioactive sphingolipid metabolite produced by sphingosine kinases-1 and −2 (SPHK1 and SPHK2). Elevated SPHK1 has been found in numerous cancer types and been shown to co...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Biol Ther
Main Authors: LeBlanc, Francis R, Liu, Xin, Hengst, Jeremy, Fox, Todd, Calvert, Valerie, Petricoin, Emanuel F, Yun, Jong, Feith, David J, Loughran, Thomas P
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2015
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4847818/
https://ncbi.nlm.nih.gov/pubmed/26252351
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2015.1078949
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados